OBINUTUZUMAB

16929 reported adverse events

Drug classes: CD20-directed Cytolytic Antibody [EPC]

These side effects are most commonly reported by patients taking OBINUTUZUMAB:

# Side effect Count
0 OFF LABEL USE 1999
1 NEUTROPENIA 1407
2 COVID-19 1094
3 FEBRILE NEUTROPENIA 1049
4 PYREXIA 1027
5 THROMBOCYTOPENIA 963
6 DISEASE PROGRESSION 961
7 INFUSION RELATED REACTION 882
8 PNEUMONIA 805
9 ANAEMIA 737
See all common reactions for OBINUTUZUMAB

OBINUTUZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DISSEMINATED ENTEROVIRAL INFECTION 8 0.4444
1 FOLLICULAR LYMPHOMA REFRACTORY 27 0.4154
2 FOLLICULAR LYMPHOMA RECURRENT 32 0.4000
3 FOLLICULAR LYMPHOMA 185 0.2102
4 MANTLE CELL LYMPHOMA REFRACTORY 13 0.1970
5 AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT 14 0.1573
6 SPLEEN ATROPHY 9 0.1525
7 FOLLICULAR LYMPHOMA STAGE IV 6 0.1463
8 APOPTOTIC COLONOPATHY 11 0.1325
9 MENINGITIS ENTEROVIRAL 12 0.1290
See all enriched reactions for OBINUTUZUMAB